M
Mukesh Bairwa
Researcher at All India Institute of Medical Sciences
Publications - 13
Citations - 43
Mukesh Bairwa is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Procalcitonin. The author has an hindex of 1, co-authored 13 publications receiving 6 citations.
Papers
More filters
Journal ArticleDOI
Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis
TL;DR: In this article, a single-center study, records of 249 patients hospitalized with COVID-19 were studied for hematological profile and biochemical markers, which might support clinical decisions to identify high fatality cases and poor diagnosis in the initial admission phase.
Journal ArticleDOI
Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study.
TL;DR: The predictors associated with critical illness and mortality based on symptoms at the time of admission and initial physical examination findings in patients with SARS-CoV-2, a new challenge to the medical fraternity, are explored.
Journal ArticleDOI
Systolic dysfunction in asymptomatic type 2 diabetic patients, a harbinger of microvascular complications: A cross-sectional study from North India.
TL;DR: It was found that sub-clinical left ventricular dysfunction was found in significantly high proportion among patients with microvascular complications, and routine screening of all diabetics for such complications and subsequently high-risk patients undergoing strain echocardiography can be a very cost-effective diagnostic, therapeutic and prognostic modality.
Journal ArticleDOI
Effectiveness of the Internet-Based Versus Face-to-Face Interaction on Reduction of Tobacco Use Among Adults: A Meta-Analysis
Journal ArticleDOI
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19.
Prasan Kumar Panda,Budha O Singh,Bikram Moirangthem,Yogesh Bahurupi,Sarama Saha,Girraj Saini,Minakshi Dhar,Mukesh Bairwa,Venkatesh S. Pai,Ankit Agarwal,Girish Sindhwani,Shailendra Handu,Ravi Kant +12 more
TL;DR: In this paper, the authors evaluated the therapeutic potential of hydroxychloroquine and lopinavir-ritonavir in combination with ribavirin in mild-severe COVID-19 infection.